首页> 外文期刊>Diabetes >Oxytocin Improves β-Cell Responsivity and Glucose Tolerance in Healthy Men
【24h】

Oxytocin Improves β-Cell Responsivity and Glucose Tolerance in Healthy Men

机译:催产素改善健康男性的β细胞反应性和葡萄糖耐量

获取原文
获取原文并翻译 | 示例
       

摘要

In addition to its pivotal role in psychosocial behavior, the hypothalamic neuropeptide oxytocin contributes to metabolic control by suppressing eating behavior. Its involvement in glucose homeostasis is less clear, although pilot experiments suggest that oxytocin improves glucose homeostasis. We assessed the effect of intranasal oxytocin (24 IU) administered to 29 healthy, fasted male subjects on glucose homeostasis measured by means of an oral glucose tolerance test. Parameters of glucose metabolism were analyzed according to the oral minimal model. Oxytocin attenuated the peak excursion of plasma glucose and augmented the early increases in insulin and C-peptide concentrations in response to the glucose challenge, while slightly blunting insulin and C-peptide peaks. Oral minimal model analyses revealed that oxytocin compared with placebo induced a pronounced increase in β-cell responsivity (PHI_(total)) that was largely due to an enhanced dynamic response (PHI_d), and a more than twofold improvement in glucose tolerance (disposition index). Adrenocorticotropic hormone (ACTH), cortisol, glucagon, and nonesterified fatty acid (NEFA) concentrations were not or were only marginally affected. These results indicate that oxytocin plays a significant role in the acute regulation of glucose metabolism in healthy humans and render the oxytocin system a potential target of antidiabetic treatment.
机译:下丘脑神经肽催产素除了在社会心理行为中起关键作用外,还通过抑制进食行为来促进代谢控制。尽管先导实验表明催产素可以改善葡萄糖稳态,但它与葡萄糖稳态的关系尚不清楚。我们评估了通过口服葡萄糖耐量试验对29名健康,禁食的男性受试者进行鼻内催产素(24 IU)对葡萄糖稳态的影响。根据口服最小模型分析葡萄糖代谢的参数。催产素减弱了血浆葡萄糖的峰值偏移,并增加了胰岛素和C肽浓度的早期增加,以响应葡萄糖挑战,同时使胰岛素和C肽的峰值略微减弱。口服最小模型分析显示,催产素与安慰剂相比可显着提高β细胞反应性(PHI_(total)),这主要是由于动态反应(PHI_d)增强,以及葡萄糖耐量(处置指数)提高了两倍以上)。促肾上腺皮质激素(ACTH),皮质醇,胰高血糖素和非酯化脂肪酸(NEFA)的浓度未受到影响,或仅受到轻微影响。这些结果表明催产素在健康人的葡萄糖代谢的急性调节中起重要作用,并使催产素系统成为抗糖尿病治疗的潜在靶标。

著录项

  • 来源
    《Diabetes》 |2017年第2期|264-271|共8页
  • 作者单位

    Department of Internal Medicine Ⅰ, University of Luebeck, Luebeck, Germany;

    Department of Internal Medicine Ⅰ, University of Luebeck, Luebeck, Germany;

    Department of Internal Medicine Ⅰ, University of Luebeck, Luebeck, Germany;

    Department of Internal Medicine Ⅰ, University of Luebeck, Luebeck, Germany;

    Department of Information Engineering, University of Padua, Padua, Italy;

    Department of Information Engineering, University of Padua, Padua, Italy;

    Department of Internal Medicine Ⅰ, University of Luebeck, Luebeck, Germany;

    Department of Medical Psychology and Behavioural Neurobiology, University of Tuebingen, Tuebingen, Germany ,German Center for Diabetes Research (DZD), Tuebingen, Germany ,Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tuebingen (IDM), Tuebingen, Germany;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:46:07

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号